Vir Biotechnology (VIR) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$497.8 million.
- Vir Biotechnology's Enterprise Value rose 4523.02% to -$497.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$497.8 million, marking a year-over-year increase of 4523.02%. This contributed to the annual value of -$901.0 million for FY2024, which is 4043.21% up from last year.
- According to the latest figures from Q3 2025, Vir Biotechnology's Enterprise Value is -$497.8 million, which was up 4523.02% from -$598.7 million recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Enterprise Value ranged from a high of -$497.8 million in Q3 2025 and a low of -$2.4 billion during Q4 2022
- For the 5-year period, Vir Biotechnology's Enterprise Value averaged around -$1.3 billion, with its median value being -$1.1 billion (2024).
- Per our database at Business Quant, Vir Biotechnology's Enterprise Value plummeted by 31949.74% in 2022 and then surged by 4865.06% in 2024.
- Over the past 5 years, Vir Biotechnology's Enterprise Value (Quarter) stood at -$565.0 million in 2021, then plummeted by 319.5% to -$2.4 billion in 2022, then surged by 36.18% to -$1.5 billion in 2023, then skyrocketed by 40.43% to -$901.0 million in 2024, then soared by 44.75% to -$497.8 million in 2025.
- Its last three reported values are -$497.8 million in Q3 2025, -$598.7 million for Q2 2025, and -$790.9 million during Q1 2025.